Advanced Biomed Inc ADVB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $5.14
- Day Range
- $4.75–5.01
- 52-Week Range
- $3.62–23.80
- Bid/Ask
- $3.10 / $5.12
- Shares Outstanding
- 1.65M
- Market Cap
- $8.06M
- Volume/Avg
- 10,722 / 2M
Key Statistics
- Price/Earnings (Normalized)
- 1.12
- Price/Sales
- 50.64
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Advanced Biomed Inc operates through its subsidiary as an AI financial verification company focused on financial verification and other professional, regulated use cases. The Group develops and operates the FinTruth Financial Verification Agent Platform (FinTruth), an enterprise AI financial verification platform designed to compare and verify financial analysis and AI-generated financial content against underlying source documents and financial rules, and to produce source-traceable and auditable results. It focuses on establishing recurring and usage-based enterprise revenue from its AI technology operations. The Group has one reportable segment, consisting mainly of its technology and software-related operations.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- —
- Total Number of Employees
- 12
- Website
- http://www.advb.ai
Valuation
|
Metric
|
ADVB
|
|---|---|
Price/Earnings (Normalized) | 1.12 |
Price/Book Value | 0.69 |
Price/Sales | 50.64 |
Price/Cash Flow | — |
Price/Earnings
ADVB
Financial Strength
|
Metric
|
ADVB
|
|---|---|
Quick Ratio | 9.33 |
Current Ratio | 9.33 |
Interest Coverage | −891.85 |
Quick Ratio
ADVB
Profitability
|
Metric
|
ADVB
|
|---|---|
Return on Assets (Normalized) | −34.46% |
Return on Equity (Normalized) | −59.21% |
Return on Invested Capital (Normalized) | −58.99% |
Return on Assets
ADVB
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|>yv@B##R | LOCK|$Z | $249B | |||
| Danaher Corp
DHR
| LOCK|Jy?mjHf | LOCK|v%& | $158B | |||
| Agilent Technologies Inc
A
| LOCK|x^F&%!$ | LOCK|$qQ | $49B | |||
| IQVIA Holdings Inc
IQV
| LOCK|Z<!v!Kb | LOCK|zy&Rw | $43B | |||
| Waters Corp
WAT
| LOCK|<nwc$Q | LOCK|k< | $43B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|sT$pHvG? | LOCK|X# | $42B | |||
| Illumina Inc
ILMN
| LOCK|K<<cypy | LOCK|?GXS | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|<QZNZ<@ | LOCK|?MM?? | $32B | |||
| Quest Diagnostics Inc
DGX
| LOCK|r>?B$Lw | LOCK|bMxM$ | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|!BPtr#Z# | LOCK|Jhyh | $26B |
United States